Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR5B21 Inhibitors

OR5B21, a member of the olfactory receptor gene family, represents a unique focal point for research into the modulation of gene expression. As with other olfactory receptors-which are integral to the detection of volatile compounds in the olfactory system-OR5B21 is presumed to encode a protein that participates in the complex signaling pathways responsible for the sense of smell. The expression of OR5B21, like other genes, is subject to intricate regulatory mechanisms that govern where, when, and how much of the protein is produced. In the pursuit of understanding these regulatory mechanisms, a variety of chemical compounds have been identified that can potentially inhibit the expression of such genes. These inhibitors can act at multiple levels of gene expression, including transcription, mRNA processing, and translation, each affecting the ultimate level of protein synthesized within the cell. Chemical inhibitors such as Doxorubicin could potentially downregulate OR5B21 by intercalating into DNA, preventing the transcriptional enzymes from accessing the gene, thus reducing its expression. Trichostatin A, a histone deacetylase inhibitor, might lead to the altered chromatin state that can suppress the gene's transcription. Similarly, 5-Azacytidine could induce hypomethylation at the DNA level, leading to the transcriptional silencing of OR5B21. Transcription inhibitors like Actinomycin D bind to DNA and inhibit RNA polymerase action, thereby decreasing OR5B21 mRNA synthesis. Further along the gene expression pathway, Pladienolide B and other spliceosome inhibitors might disrupt proper mRNA splicing of OR5B21 pre-mRNA, while translation inhibitors like Rapamycin and Neomycin could decrease the synthesis of OR5B21 protein by acting on the translation machinery. Additionally, proteasome inhibitors such as Bortezomib may decrease protein levels by promoting the degradation of improperly folded proteins, including OR5B21. Each of these compounds represents a potential tool for elucidating the biological role of OR5B21 by selectively diminishing its presence in the cellular environment.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin, by intercalating into DNA, could obstruct the transcription machinery from accessing the OR5B21 gene, thereby downregulating its expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

By inhibiting histone deacetylases, Trichostatin A would cause hyperacetylation of histones, potentially leading to the chromatin remodeling that results in the decreased expression of the OR5B21 gene.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine might incorporate into the OR5B21 gene locus, leading to hypomethylation and transcriptional silencing, hence reducing the expression of the OR5B21 protein.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

This compound binds to the DNA at the transcription initiation complex, potentially halting the transcription of OR5B21 mRNA, which would result in lower levels of OR5B21 protein.

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$290.00
$5572.00
$10815.00
$25000.00
$65000.00
$2781.00
63
(2)

The binding of Pladienolide B to the spliceosome could lead to defective mRNA splicing of the OR5B21 pre-mRNA, possibly resulting in nonsense-mediated decay and decreased levels of functional OR5B21 protein.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits the mTOR pathway, which is crucial for mRNA translation. Inhibition of this pathway could lead to a reduction in the synthesis of the OR5B21 protein.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Bortezomib inhibits the 26S proteasome, potentially causing an accumulation of ubiquitinated OR5B21 proteins, which may lead to enhanced degradation and a consequent decrease in the level of OR5B21 protein.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$66.00
$153.00
16
(2)

17-AAG disrupts the function of heat shock protein 90 (HSP90), which may lead to the destabilization and degradation of client proteins, including potentially OR5B21, resulting in its reduced expression.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Thalidomide could downregulate the expression of OR5B21 by inhibiting the synthesis of transcription factors or the signaling pathways that control the transcription of the OR5B21 gene.

Neomycin sulfate

1405-10-3sc-3573
sc-3573A
1 g
5 g
$26.00
$34.00
20
(5)

Neomycin, by binding to ribosomal RNA, could inhibit the translation of mRNA, potentially leading to reduced synthesis of the OR5B21 protein due to decreased translation efficiency.